Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Implants / Devices
    • Faulty breast...

    Faulty breast implants-400 Swedish women win compensation

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-11-30T09:45:53+05:30  |  Updated On 30 Nov 2018 9:45 AM IST
    Faulty breast implants-400 Swedish women win compensation

    France: A French court on Thursday ordered the German safety certifier that approved defective breast implants for use to compensate around 400 Swedish women who received the devices behind a global health scare.


    The court in the Paris suburb of Nanterre ordered TUV to pay 4,600 euros ($5,200) to each of the Swedish plaintiffs for the harm caused by approving implants made by French firm Poly Implant Prothese (PIP).


    It also ordered the company to reimburse the cost of having the implants -- which were filled with a cheap industrial-grade silicone gel used in electronic equipment -- removed.


    It comes a month after France's highest appeals court ordered that TUV is retried for negligence over its role in the affair, after being initially cleared of liability by a lower court.


    After a separate trial, the company had already been ordered to pay 60 million euros ($69 million) as a deposit for potential compensation for 20,000 women who received the defective implants.


    The PIP implant scandal made global headlines in 2011 after doctors first noticed abnormally high rupture rates in the implants.


    Some 400,000 worldwide, mostly in Latin America, are believed to have received the enhancements.


    Thousands had them removed, despite health authorities in several countries declaring them not to be toxic.


    PIP's founder, Jean-Claude Mas, was convicted of fraud and sentenced to four years in jail. His company was shut down in 2010.


    Also Read: Faulty Implant: J&J launches IPAP Reimbursement Programme
    breast implantscompensationdefective breastFrancehealth scareJean Claude Maspip implantpoly implantPoly Implant ProtheseSwedentuv
    Source : AFP

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok